Clinical Trial Update: WHARTON JELLY ORIGINATED MESENCHIAL STEM CELL in GONARTHROSIS [Phase 2]

View source ↗

Summary

Phase 2 trial update on Wharton jelly-derived mesenchymal stem cells for gonarthrosis is in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gonarthrosis

Drugs mentioned

• Wharton jelly-derived mesenchymal stem cells (Wharton jelly-derived mesenchymal stem cells)

Snippet

Sponsor: TC Erciyes University | Conditions: Stem Cell, Gonarthrosis | Phase 2 | Status: UNKNOWN